ISMETT Ranks Among Best in Italy for Patient Outcomes, Credits Strong UPMC Partnership
PITTSBURGH, Dec. 3, 2015 – ISMETT, a leading Italian transplant hospital managed by UPMC, was recently ranked among the top hospitals in the country based on 30-day mortality rates following cardiac, thoracic and abdominal surgeries.
The rankings, published in the 2015 edition of the Programma Nazionale Esiti organized by Agenas, the Italian national agency for regional health care services, shows Palermo-based ISMETT as the leader among all regional, public hospitals based on its 2014 results and among the top performers nationally for both public and private hospitals.
Specifically, ISMETT had a 30-day mortality rate of 0 percent after lung, liver and colon cancer surgery, compared with the national averages of 1.3 percent, 2.65 percent and 4.07 percent respectively. ISMETT’s 30-day mortality rate after a heart valve replacement was 0.93 percent vs. the national average of 2.84 percent.
“Thanks to the close collaboration of the doctors, nurses, technicians and other staff working at ISMETT, our patient outcomes are among the very best in the nation and the world,” said Bruno Gridelli, M.D., chief executive officer of ISMETT. “The connection between us and our colleagues at UPMC in Pittsburgh, a leading academic medical center, is a powerful tool for our continuous improvement and ensures that our medical knowledge and competencies remain at the highest levels.”
Added Charles Bogosta, president of UPMC International, “ISMETT’s stellar results show what can be achieved when forward-thinking health care leaders worldwide partner with UPMC to re-think the way that patient care is delivered close to home.” UPMC provides hands-on health care consulting and management services in more than a dozen countries.
The Agenas hospital assessment program, started in 2010, examines efficacy, safety, efficiency and quality of clinical services using 146 indicators, as reported by Italian hospitals. Surgical mortality indicators were added to the report this year.
Formally known as the Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione, ISMETT has performed more than 1,600 transplants since it began operations in 1999 and tens of thousands of high specialty procedures, including cardiothoracic and cancer surgeries. An example of innovative and efficient clinical management, ISMETT is a public-private partnership between UPMC and the Region of Sicily, through ARNAS Civico hospital in Palermo. ISMETT is the only hospital in Italy designed and intended exclusively for solid organ transplantation and highly specialized therapies. It treats more than 30,000 patients a year with severe organ disease and was recently accredited for the third time by Joint Commission International
(JCI), the organization that certifies the safety and quality of care provided to patients in hospitals around the world.